Skip to main content

Table 1 Clinical characteristics of the study patients according to T2DM

From: Polymorphism rs189037C > T in the promoter region of the ATM gene may associate with reduced risk of T2DM in older adults in China: a case control study

Variables

T2DM group (n = 80)

Control group (n = 80)

Wilcoxon W or χ2

P value

FPG (mmol/L)

8.04 ± 3.34

5.29 ± 1.60

4272.5

0.000*

UA (mmol/L)

328.02 ± 98.48

346.02 ± 100.18

5779.5

0.508

TG (mmol/L)

1.59 ± 0.66

1.56 ± 0.72

5960.0

0.465

TC (mmol/L)

3.92 ± 1.11

4.17 ± 1.14

5283.0

0.217

LDL-C (mmol/L)

2.29 ± 0.83

2.39 ± 0.82

5441.0

0.511

HDL-C (mmol/L)

1.11 ± 0.27

1.24 ± 0.33

4870.5

0.006*

Smoking, n (%)

45 (56.3)

41 (51.3)

0.40

0.526

CAD, n (%)

67 (83.8)

54 (67.5)

5.73

0.017*

Hypertension, n (%)

54 (67.5)

39 (48.8)

5.78

0.016*

  1. T2DM Type 2 diabetes mellitus, FPG Fasting plasma glucose, UA Uric acid, TG Triglycerides, TC Total cholesterol, LDL-C Low-density lipoprotein cholesterol, HDL-C High-density lipoprotein cholesterol, CAD Coronary artery disease
  2. *: P < 0.05